Charles R Drew University Master of Science and Clinica*

描述（由申请人提供）： 在回应RFA-AR-01-009题为“临床研究教育和职业发展在少数民族机构”，查尔斯R。医学和科学（德鲁）德鲁大学正计划通过医学院建立一个临床研究学位课程（MSCR）的科学硕士。该计划代表了一个巨大的进步，因为它将成为通过医学院提供的第一个独立学位。目前，医学博士学位是通过德鲁与加州大学洛杉矶分校医学院的联系共同授予的。该计划代表了德鲁的新课程，不仅将利用德鲁的教师，还将利用加州大学洛杉矶分校附属机构的教师，包括最近资助的加州大学洛杉矶分校K-30转化研究课程奖的教师。总体目标是培养合格的候选人在临床研究方法，并传授影响临床研究如何有助于改善我们多元化国家的医疗保健的文化和伦理问题的独特理解。核心课程包括流行病学，生物统计学，临床试验，药物遗传学，研究伦理学，科学传播和遗传学等领域。在德鲁MSCR计划的具体目标是： 1.实施新的面向患者的研究课程，特别强调解决健康差距的方法。 2.增加在健康差距研究方面受过良好培训的妇女和少数民族调查员的人数。 3.培养一支训练有素的临床教师队伍，他们将对不成比例地影响少数民族人口的疾病进行临床研究。 4.持续评估MSCR计划的流程和初始目标，并利用这些评估与NIH计划官员协商，进行持续的计划改进。

DESCRIPTION (provided by applicant): In response to the RFA-AR-01-009 entitled "Clinical Research Education and Career Development in Minority Institutions", the Charles R. Drew University of Medicine and Science (Drew) is planning to establish a Master of Science in Clinical Research Degree Program (MSCR) through the College of Medicine. This program represents a dramatic advancement as it will become the first independent degree offered through the College of Medicine. Presently, the Doctor of Medicine degree is jointly conferred through Drew's affiliation with the UCLA School of Medicine. This program represents a new curriculum at Drew that will utilize faculty not only from Drew, but also from the affiliated UCLA institutions, including faculty teaching the recently funded UCLA K-30 Translational Research Curriculum Award. The overarching goal is to train qualified candidates in clinical research methodologies and to impart a unique understanding of the cultural and ethical issues that impact how clinical investigation can contribute to improving the health care of our diverse nation. The core curriculum includes areas such as epidemiology, biostatistics, clinical trials, pharmaco-genetics, research ethics, the communication of science, and grantsmanship. The specific aims of the MSCR Program at Drew are to: 1. Implement a new curriculum for patient-oriented research that has a particular emphasis on methodologies to address health disparities. 2. Increase the number of women and ethnic minority investigators well-trained in health disparities research. 3. Develop a cadre of well-trained clinician faculty who will pursue clinical research on diseases that disproportionately affects minority populations. 4. Continuously evaluate the processes and the initial objectives of the MSCR program and utilize these assessments to make ongoing programmatic improvements in consultation with NIH program officials.